Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

INVAGEN PHARMS

  • FDA Approval
  • Feb. 28, 2024, 09:52 UTC
  • 47
  • 0 comments

FDA approve LURASIDONE HYDROCHLORIDE

Comment Full text

THERATECHNOLOGIES

  • FDA Approval
  • Feb. 28, 2024, 09:52 UTC
  • 46
  • 0 comments

FDA approve TESAMORELIN ACETATE

Comment Full text

GLENMARK PHARMS LTD

  • FDA Approval
  • Feb. 28, 2024, 09:52 UTC
  • 45
  • 0 comments

FDA approve DROSPIRENONE; ETHINYL ESTRADIOL

Comment Full text

MERCK SHARP DOHME

  • FDA Approval
  • Feb. 27, 2024, 17:57 UTC
  • 56
  • 0 comments

FDA approve BELZUTIFAN

Comment Full text

MYLAN LABS LTD

  • FDA Approval
  • Feb. 27, 2024, 09:40 UTC
  • 47
  • 0 comments

FDA approve DOCETAXEL

Comment Full text

NOVAST LABS

  • FDA Approval
  • Feb. 27, 2024, 09:40 UTC
  • 48
  • 0 comments

FDA approve TOPOTECAN HYDROCHLORIDE

Comment Full text

ALKEM LABS LTD

  • FDA Approval
  • Feb. 27, 2024, 09:40 UTC
  • 49
  • 0 comments

FDA approve LANSOPRAZOLE

Comment Full text

PADAGIS ISRAEL

  • FDA Approval
  • Feb. 27, 2024, 09:40 UTC
  • 44
  • 0 comments

FDA approve BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE

Comment Full text

EUGIA PHARMA

  • FDA Approval
  • Feb. 27, 2024, 09:40 UTC
  • 51
  • 0 comments

FDA approve ESOMEPRAZOLE SODIUM

Comment Full text

XIROMED

  • FDA Approval
  • Feb. 27, 2024, 09:40 UTC
  • 48
  • 0 comments

FDA approve GUANFACINE HYDROCHLORIDE

Comment Full text
  • Previous
  • 540
  • 541
  • 542
  • 543
  • 544
  • Next

Search

News categories

  • Technical Exchange News(13116)
  • Event(6229)
  • SEC News(328517)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(183573)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin